Clinical Trial Update: Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an autologous tumor cell and dendritic cell vaccine for metastatic melanoma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous tumor cell and dendritic cell vaccine (autologous tumor cell-dendritic cell vaccine)

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED